To our knowledge, this study is the largest to date performed on CSF neurofilament light chain protein concentrations in clinically diagnosed FTD, and also the first study on NFL levels in neuropathologically verified FTD with pathological subtyping. The gene discussed is NEFL; the disease is frontotemporal dementia.